2-oxothiazolidine-4-carboxylic acid has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahern, J; Hodge, G; Hodge, S; Holmes, M; Jersmann, H; Matthews, G; Mukaro, V; Reynolds, PN; Shivam, A | 1 |
1 other study(ies) available for 2-oxothiazolidine-4-carboxylic acid and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Cigarette smoke-induced changes to alveolar macrophage phenotype and function are improved by treatment with procysteine.
Topics: Animals; Apoptosis; Bronchoscopy; Flow Cytometry; Humans; Inflammation; Interleukin-12; Interleukin-1beta; Macrophages; Macrophages, Alveolar; Mice; Phagocytosis; Phenotype; Pulmonary Disease, Chronic Obstructive; Pyrrolidonecarboxylic Acid; Smoking; Thiazolidines; Tumor Necrosis Factor-alpha | 2011 |